ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2008-12-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2008.100826PMID 19060001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

  2008cited by this paper
• Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

  2008cited by this paper
• Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

  2008cited by this paper
• Effect size, confidence interval and statistical significance: a practical guide for biologists

  2007cited by this paper
• Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.

  2005cited by this paper
• The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.

  2005cited by this paper
• Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.

  2002cited by this paper
• Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.

  2001cited by this paper
• The OMERACT filter for Outcome Measures in Rheumatology.

  1998cited by this paper
• A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

  1994cited by this paper
• Measures to assess ankylosing spondylitis: taxonomy, review and recommendations.

  1993cited by this paper
• Validity of single variables and indices to measure disease activity in rheumatoid arthritis.

  1993cited by this paper
• Validity of single variables and indices to measure disease activity in rheumatoid arthritis.

  1993cited by this paper

• Psychometric validation of the Bulgarian Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire: linking quality of life with disease activity in axial spondyloarthritis.

  2026cites this paper
• The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register.

  2026cites this paper
• Vascular effects of achieving low disease activity in axial spondyloarthritis - A 2-year prospective treat-to-target study.

  2026cites this paper
• Clinical assessment of Psoriatic Arthritis.

  2026cites this paper
• Clinico-epidemiological characteristics of patients with ankylosing spondylitis: experience from a specialized rheumatology centre in Bangladesh

  2025cites this paper
• Annals of the Rheumatic Diseases collection on axial spondyloarthritis (2022-2024): advances in the field.

  2025cites this paper
• Prediction model for psychological disorders in ankylosing spondylitis patients based on multi-label classification

  2025cites this paper
• Defining Bath Ankylosing Spondylitis Disease Activity Index Cut‐off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis

  2025cites this paper
• Low Bone Turnover, Mineralization Impairment, and Cortical Alterations in Patients with Axial Spondyloarthritis: A Histomorphometric Study

  2025cites this paper
• Impact of tumour necrosis factor-α inhibitors on non-invasive indices of hepatic steatosis and fibrosis in patients with ankylosing spondylitis

  2025cites this paper
• The Impact of TLR4 rs41426344 Polymorphism on Ankylosing Spondylitis Disease Activity: A Study in Turkish Patients

  2025cites this paper
• Predictors for Improvement of Global Functioning in Patients with Axial Spondyloarthritis

  2025cites this paper
• Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial.

  2025cites this paper
• The Factors Related to Work Productivity and Disease Costs in Patients with Ankylosing Spondylitis

  2025influential citation
• Long-term comparative analysis of secukinumab versus TNFα inhibitors in patients with spondyloarthritis: treatment persistence is differentially affected by disease phenotype, obesity and sex

  2025cites this paper
• Evaluation of sarcopenia in patients with spondyloarthritis

  2025cites this paper
• Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life.

  2025cites this paper
• Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis

  2025cites this paper
• Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level

  2025cites this paper
• Assessing Disease Activity in Axial Spondyloarthritis: Finding the Balance Between the Bath Ankylosing Spondylitis Disease Activity Index and Axial Spondyloarthritis Disease Activity Score

  2025cites this paper
• Exploring Exercise Perceptions and Physical Activity Levels in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Comparative Study.

  2025cites this paper
• Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort

  2025cites this paper
• Retrospective Analysis of Spinal Radiographs for the Presence of Lumbosacral Transitional Vertebra in Patients with Axial Spondyloarthritis

  2025cites this paper
• RheuMetric Physician 0 to 10 Estimates of Inflammation, Damage, and Patient Distress at Initial Versus Follow‐Up Visits in Contemporary Rheumatology Care

  2025cites this paper
• Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real‐World Study in Taiwan

  2025cites this paper
• Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling

  2025cites this paper
• Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease

  2025cites this paper
• The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA

  2025cites this paper
• Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience

  2025cites this paper
• Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased

  2025cites this paper
• Fatigue and kinesiophobia in axial spondyloarthritis: Exploring the role of disease activity, functional impairment, and psychological factors

  2025cites this paper
• IL- 33 and sST- 2 association with carotid intima-media thickness in patients with Ankylosing Spondylitis

  2025cites this paper
• Minimal seasonal variation in disease parameters of axial spondyloarthritis: a register-based study

  2025cites this paper
• Microbiome abundance of Prevotellaceae in spondyloarthritis patients with positive depression screening: A cross-sectional analysis.

  2025cites this paper
• Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience

  2025cites this paper
• Piriformis muscle abnormalities in sacroiliac MRI of patients with axial spondyloarthritis

  2025cites this paper
• Global research trends in biological therapy for ankylosing spondylitis: A comprehensive visualization and bibliometric study (2004–2023)

  2025cites this paper
• CLINICAL AND RADIOGRAPHIC (CBCT) FEATURES OF TMJ IN RELATION TO DISEASE ACTIVITY AND DURATION IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS PATIENT

  2025cites this paper
• Espondiloartritis

  2025cites this paper
• [Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases].

  2025cites this paper
• Comprehensive Oxidative Stress Profiling and Clinical Correlates in Spondyloarthritis: The Role of Glutathione Peroxidase and Modifiable Lifestyle Factors

  2025cites this paper
• 1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritis.

  2025cites this paper
• The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs

  2025cites this paper
• Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study

  2025cites this paper
• The Influence of Different Phrasing of the “Patient Global Assessment of Global Health” on the Patient’s Rating and Disease Activity Score in Ankylosing Spondylitis

  2025cites this paper
• Monitoring psoriatic arthritis in research and clinical practice

  2025cites this paper
• The Association Between Obesity Indices and Non-Alcoholic Fatty Liver Disease in Patients with Ankylosing Spondylitis

  2025cites this paper
• Correlations among quality of life, spinal mobility, and disease activity in early-treated axial spondyloarthritis: a single-center cross-sectional study

  2024cites this paper
• Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?

  2024cites this paper
• Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey

  2024cites this paper
• Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol

  2024cites this paper
• T2* cartilage mapping in early axial spondyloarthritis: diagnostic accuracy and correlation with clinical characteristics, sacroiliitis MRI scorings, and diffusion metrics

  2024cites this paper
• Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies

  2024cites this paper
• Hematological indices: potential markers of disease activity in ankylosing spondylitis patients treated with biological drugs

  2024cites this paper
• Long-term association between physical activity and global functioning in patients with axial spondyloarthritis: results of a two-year prospective study

  2024cites this paper
• Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia

  2024cites this paper
• C-reactive protein/albumin ratio and its improvement with disease activity among axial spondyloarthritis and psoriatic arthritis patients: A prospective study

  2024cites this paper
• Factors Associated with Axial Spondyloarthritis Remission in a Cohort of Saudi Patients with Longstanding Disease: A Multicenter Prospective Cohort Study

  2024cites this paper
• Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis

  2024cites this paper
• Serum Level of Interleukin-33 in Ankylosing Spondylitis Patients and Its Relation with Disease Parameters

  2024cites this paper
• Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering

  2024cites this paper
• Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy

  2024cites this paper
• Association of trabecular bone score with disease parameters and vertebral fractures in axial spondyloarthritis

  2024cites this paper
• The effectiveness of tumor necrosis factor-α blocker therapy in patients with axial spondyloarthritis who failed conventional treatment: a comparative study focused on improvement in ASAS Health Index

  2024cites this paper
• Looking back on 51 years of the Carol Nachman Prize in Rheumatology—significance for the field of spondyloarthritis research

  2024cites this paper
• Diagnosis, monitoring, and management of axial spondyloarthritis

  2024cites this paper
• Raftlin – a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study

  2024cites this paper
• Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

  2024cites this paper
• Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study

  2024cites this paper
• Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2

  2024cites this paper
• Exploring associations with depressive and anxiety symptoms among Syrian patients with ankylosing spondylitis undergoing biological treatment: A cross-sectional study

  2024cites this paper
• Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine

  2024cites this paper
• Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity

  2024cites this paper
• Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging

  2024cites this paper
• Ultrasonographic Evaluation of Nail Involvement in Patients With Axial Spondyloarthritis

  2024cites this paper
• Comparing the construct validity of measurement instruments for pain and stiffness in patients with axial spondyloartwhritis: cross-sectional analysis in the OASIS cohort

  2024cites this paper
• Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation

  2024cites this paper
• Pan-immune inflammation value as a biomarker in ankylosing spondilitis and associated with disease activity

  2024cites this paper
• Advances in the management of psoriatic arthritis in adults

  2024cites this paper
• Different disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years

  2024cites this paper
• Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy

  2024cites this paper
• A single-center experience: Enteropathic arthritis in inflammatory bowel diseases

  2024cites this paper
• The Effect of Alcohol Consumption on Clinical Outcomes and Structural Damage in Patients with Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis.

  2024cites this paper
• Higher levels of physical activity are associated with less evasive coping, better physical function and quality of life in patients with axial spondyloarthritis

  2024cites this paper
• Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA

  2024cites this paper
• Minimal clinical datasets for spine related musculoskeletal disorders in primary and outpatient care settings: a scoping review.

  2023cites this paper
• Ankylosing spondylitis impact on knee cartilage thickness: correlation with demographic data and clinical characteristics

  2023cites this paper
• Exploring physical function and physical activity in axial spondyloarthritis: Beyond clinical remission or low disease activity

  2023cites this paper
• The ASAS Health Index and Environmental Factors Item Set: validity and reliability of the Swedish translations in Swedish patients with ankylosing spondylitis

  2023cites this paper
• The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry

  2023cites this paper
• Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study.

  2023cites this paper
• Radiological progression and predictive factors in psoriatic arthritis: insights from a decade-long retrospective cohort study

  2023cites this paper
• Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care

  2023cites this paper
• Measuring response to treatment in axial spondyloarthritis using quantitative imaging biomarkers: a prospective observational cohort study

  2023cites this paper
• Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

  2023cites this paper
• Korean treatment recommendations for patients with axial spondyloarthritis

  2023influential citation
• Korean treatment recommendations for patients with axial spondyloarthritis

  2023influential citation
• Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process

  2023cites this paper
• Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis

  2023cites this paper
• Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment.

  2023cites this paper